Recent advances in the synthetic transformation of benzimidazole scaffolds as privileged pharmacophores for cancer chemotherapy (2020–present)
Open Access
- 16 January 2026
- journal article
- research article
- Published by Springer Nature in Journal of Saudi Chemical Society
- Vol. 30 (1) , 6
Abstract
No abstract availableKeywords
Funding Information
- Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University (000)
This publication has 153 references indexed in Scilit:
- An Efficient Strategy for Quinazolinone and Benzimidazole Synthesis Using Microwave‐Assisted Copper‐Catalyzed Aerobic Oxidation of AminesChemCatChem, 2025
- Antiproliferative Activity and Molecular Docking of Some Pyrazole‐Based Quinazolinone, Benzimidazole, and Tetrazinethione DerivativesJournal of Biochemical and Molecular Toxicology, 2025
- Benzimidazole‐Containing Compounds as Anticancer AgentsChemistrySelect, 2024
- Synthesis of Benzimidazole Based 1,2,4‐Triazole Derivatives as Potential Anticancer Agents: In Silico TechniquesChemistrySelect, 2024
- Synthesis, Biological Investigation, and Molecular Docking of Novel Benzimidazole‐Hydrazone Hybrids as Potential Anticancer Agent CandidatesChemistrySelect, 2024
- In Vitro and In Silico Studies on Benzimidazole‐Based CompoundsChemistrySelect, 2024
- The medicinal panorama of benzimidazoles and their scaffolds as anticancer and antithrombotic agents: A reviewArchiv der Pharmazie, 2023
- Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targetsJournal of Heterocyclic Chemistry, 2021
- Synthesis, in vitro cytotoxicity, ADME, and molecular docking studies of benzimidazole‐bearing furanone derivativesJournal of the Chinese Chemical Society, 2020
- Synthesis, antioxidant and anticholinesterase activities of novel quinoline‐aminophosphonate derivativesJournal of Heterocyclic Chemistry, 2020